Page last updated: 2024-09-02

s 14297 and Anochlesia

s 14297 has been researched along with Anochlesia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bervoets, K; Brocco, M; Dacquet, C; Girardon, S; Gobert, A; Millan, MJ; Newman-Tancredi, A; Peglion, JL; Rivet, JM; Vian, J1
Brocco, M; Gressier, H; Millan, MJ1
Audinot, V; Bervoets, K; Brocco, M; Dekeyne, A; Desposte, I; Gluck, L; Gobert, A; Lejeune, F; Millan, MJ; Newman-Tancredi, A; Rivet, JM1

Other Studies

3 other study(ies) available for s 14297 and Anochlesia

ArticleYear
Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 275, Issue:2

    Topics: 2-Naphthylamine; Animals; Body Temperature Regulation; Catalepsy; CHO Cells; Cricetinae; Dopamine Antagonists; Furans; Humans; Male; Prolactin; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Dopamine D2; Recombinant Proteins; Stereoisomerism

1995
The dopamine D3 receptor antagonist, (+)-S 14297, blocks the cataleptic properties of haloperidol in rats.
    European journal of pharmacology, 1997, Mar-05, Volume: 321, Issue:3

    Topics: 2-Naphthylamine; Animals; Antipsychotic Agents; Avoidance Learning; Catalepsy; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Furans; Haloperidol; Male; Rats; Rats, Wistar; Receptors, Dopamine D3; Stereoisomerism

1997
A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 287, Issue:1

    Topics: 2-Naphthylamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Benzopyrans; Binding, Competitive; Biphenyl Compounds; Body Temperature; Catalepsy; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Furans; Humans; Indans; Naphthalenes; Oxazines; Piperazines; Prolactin; Pyrrolidines; Rats; Receptors, Dopamine D2; Receptors, Dopamine D3

1998